Multibic

Sodium Hydrogen Carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a solution for injection for haemodialysis and intravenous use. It provides essential electrolytes and osmotic balance during haemodialysis in patients with renal failure.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Multibic is an electrolyte solution used in renal replacement therapies to maintain fluid and electrolyte homeostasis. - Hemodialysis: Maintains electrolyte and osmotic balance during the procedure. - Renal replacement therapy: Supports patients with end‑stage kidney disease undergoing dialysis. - Peritoneal dialysis: Provides necessary electrolytes for fluid exchanges in peritoneal dialysis.

Multibic may be associated with adverse reactions related to its electrolyte composition.

Common Side Effects: - Mild hypernatremia: Slight increase in serum sodium levels. - Mild hyperkalemia: Small rise in serum potassium. - Nausea: Transient gastrointestinal discomfort. - Headache: Mild, self‑limiting.

Serious or Rare Side Effects: - Severe electrolyte imbalance: Potential for life‑threatening disturbances. - Anaphylactic reaction: Rare hypersensitivity requiring immediate intervention. - Cardiac arrhythmia: May occur with extreme electrolyte shifts.

Prior to administration, clinicians should evaluate patient-specific factors and monitor therapy closely. - Assess baseline electrolyte levels: Verify serum sodium, potassium, calcium, and magnesium. - Monitor cardiac rhythm: Detect arrhythmias early. - Use sterile equipment only: Prevent contamination. - Avoid in uncontrolled hypertension: Electrolyte shifts may exacerbate pressure. - Do not mix with incompatible solutions: Prevent precipitation. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze.

Electrolyte solutions can interact with other medications, altering electrolyte balance or causing precipitation.

Major Interactions (Avoid): - Calcium‑containing solutions: Risk of precipitation with magnesium. - High‑dose potassium supplements: May cause severe hyperkalemia. - Loop diuretics: Additive loss of electrolytes leading to imbalance.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: Monitor potassium and renal function. - Beta‑blockers: Observe blood pressure changes. - Anticoagulants: Watch for bleeding risk due to altered plasma composition.